Long-term follow up studies of hepatitis C virus (HCV) infection

No abstract

SUMMARY BackgroundClinical trials have shown that the combination of pegylated interferon ⁄ ribavirin induces a sustained virological response in 54-63% of patients with chronic hepatitis C virus infection, but its effectiveness in day-to-day clinical practice is less clear.

Patients with high S-phase fraction and/or above-normal serum AFP are at higher risk of developing HCC and should be offered a close surveillance program.

No abstract